Jap T S, Kwok C F, Ho L T
Department of Medicine, Veterans General Hospital-Taipei, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1990 Mar;45(3):191-5.
A 41-year-old male with recurrent hyperthyroidism resulting from pituitary tumor was studied. Because of recurrent hyperthyroidism, he had been treated with propylthiouracil for four years and had been operated. At the time of high serum thyroid hormone (T4: 20 micrograms/dl; T3:502 ng/dl), there was also elevated basal serum TSH level (55 microU/ml) which could not be suppressed by exogenous thyroid hormone administration. In addition, the serum TSH showed blunt response to intravenous TRH infusion. An elevated serum prolactin level was also observed (111 ng/ml). After bromocriptine administration (2.5 mg daily), the suppressibility of serum TSH level was found better than that of prolactin level. The existence of a TSH- and PRL-secreting pituitary tumor in this patient exhibited a dissociated hormonal response to low doses of dopaminergic agents.
对一名因垂体瘤导致复发性甲状腺功能亢进的41岁男性进行了研究。由于复发性甲状腺功能亢进,他接受丙硫氧嘧啶治疗四年并接受了手术。在血清甲状腺激素水平较高时(T4:20微克/分升;T3:502纳克/分升),基础血清促甲状腺激素(TSH)水平也升高(55微单位/毫升),且外源性甲状腺激素给药无法抑制该水平。此外,血清TSH对静脉注射促甲状腺激素释放激素(TRH)的反应迟钝。还观察到血清催乳素水平升高(111纳克/毫升)。给予溴隐亭(每日2.5毫克)后,发现血清TSH水平的抑制性优于催乳素水平。该患者存在分泌TSH和PRL的垂体瘤,对低剂量多巴胺能药物表现出激素反应分离。